TY - BOOK ID - 144606236 TI - CADTH Canadian Drug Expert Committee final recommendation Tesamorelin (Egrifta -- Theratechnologies Inc.) indication : HIV-associated lipohypertherapy PY - 2016 PB - Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, DB - UniCat KW - Growth hormone releasing factor. UR - https://www.unicat.be/uniCat?func=search&query=sysid:144606236 AB - ER -